Target intelligence / Profile preview

Reactive oxygen species-related and antioxidant pathways (ROS/Antioxidant pathways)

Target
ROS/Antioxidant pathways
Molecular classification
Enzyme, Transcription factor, Signal transduction pathway, Other
01

Overview

Reactive oxygen species (ROS)-related and antioxidant pathways represent a complex network of enzymatic and non-enzymatic systems dedicated to maintaining cellular redox homeostasis. Key components include enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase, as well as the master regulatory transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2). Under physiological conditions, low levels of ROS serve as critical signaling molecules for cell survival and proliferation; however, an imbalance leading to excessive ROS results in oxidative stress, causing damage to DNA, proteins, and lipids. This imbalance is a hallmark of numerous pathologies, including neurodegenerative diseases like Parkinson's, cardiovascular diseases, and chronic inflammation. Therapeutic strategies often focus on activating the Nrf2-Keap1 pathway to enhance the endogenous antioxidant response or using small molecule scavengers to mitigate oxidative damage. While promising, targeting these pathways is challenging due to the 'antioxidant paradox,' where excessive suppression of ROS can interfere with essential signaling or inadvertently protect malignant cells from apoptosis.

Other names
Antioxidant defense systemRedox signaling pathwaysOxidative stress response pathwaysNrf2-Keap1 signaling pathwayAntioxidant response element (ARE) pathway
02

Mechanism of action

Drugs targeting these pathways typically act as Nrf2 activators to induce antioxidant gene expression, ROS scavengers to directly neutralize oxidants, or inhibitors of ROS-producing enzymes like NADPH oxidase (NOX).

03

Biological functions

Redox homeostasisSignal transductionApoptosisCell proliferationImmune responseMetabolic regulation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetes mellitusAging-related disorders
05

Safety considerations

Off-target oxidative stressPotential for promoting survival of cancer cells (Nrf2 paradox)Systemic toxicity from non-specific redox modulationInterference with essential physiological ROS signaling
06

Interacting drugs

Bardoxolone methyl

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2-deoxyguanosine (8-OHdG)Glutathione (GSH/GSSG) ratioSuperoxide dismutase (SOD) activityNrf2 nuclear translocation

Beyond the preview

Go deeper on Reactive oxygen species-related and antioxidant pathways (ROS/Antioxidant pathways).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species-related and antioxidant pathways (ROS/Antioxidant pathways).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call